Ductus Arteriosus, Patent

Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight Infants

Ductus Arteriosus Closure and D-Dimer and Fibrinogen Levels

Adding Paracetamol to Ibuprofen for Treatment of Patent Ductus Arteriosus in Preterm Infants

The U.S. PDA Registry

Paracetamol vs Ibuprofen for PDA Closure in Preterm Infants.

Paracetamol in Patent Ductus Arteriosus

Analysis of the Impact of Patent Ductus Arteriosus on Brain Function in Preterm Neonates: Multimodal Approach Integrating EEG-NIRS, Ultrasound and Clinical Data

Alternative Paracetamol Treatments for the Neonate With a hsPDA

NIT-OCCLUD PDA Phase II Sentinel Trial

Reproduction and Survival After Cardiac Defect Repair

Comparing Ibuprofen And Indomethacin For The Treatment Of The Patent Ductus Arteriosus in Very Premature Babies

Trial of Indomethacin Prophylaxis in Preterm Infants (TIPP)

Patent Ductus Arteriosus (PDA) Screening Trial

Management of Patent Ductus in Premature Infants

Changes in Renal and Splanchnic Oxygenation During Ibuprofen Treatment for Patent Ductus Arterious

High-dose Ibuprofen for Patent Ductus Arteriosus (PDA) in Preterm Infant

Urine NT-proBNP Levels and Echocardiographic Findings in Very Low Birth Weight (VLBW) Infants

Plasma N-terminal proBNP Concentrations and Patent Ductus Arteriosus in Preterm Babies

Plasma B-Type Natriuretic Peptide Concentrations in Preterm Infants < 28 Weeks

New Management Strategy of PDA for VLBW Preterm Infants